Patients & Volunteers Information for those interested or currently participating in a clinical trial
	Research Sponsors Why you should choose Aurora for your clinical trials
	Investigators & Coordinators Learn more about our services
	Research Matters Quarterly newsletter about research at Aurora
	Links Learn more about clinical research
	Contact us Contact the Clinical Research department
	Return home Return to the Clinical Research home page

Select from the search options to widen or narrow the search results.

Do you or someone you know suffer from Erosive Gastroesophageal Reflux Disease (eGERD)?

The Clinical Research Department at Aurora Health Care is conducting a clinical research study to compare two study drugs in how they heal erosions of the esophagus and provide erosive gastroesophageal reflux disease (eGERD) symptom relief.

Qualified Participants must be/have:

• Male or female, ages 18-75
• A history of GERD symptoms for at least 3 months immediately before screening
• Heartburn for at least 2 days a week for at least 1 month before screening
• Be willing to complete a daily diary
• No inflammatory bowel disease
• No unstable type II diabetes

Qualified participants will be asked to complete up to 4-6 visits. Your participation may last up to 3 months.

All study-related exams and procedures, laboratory tests, and study medication will be provided at no cost to qualified participants.

For more information, please contact:

Stacie Snap, CCRC 414-219-5348

stacie.snap@aurora.org

Aboud Affi, MD, Principal Investigator

Clinical trial location(s)

[ previous page ]

Copyright Aurora Health Care, a not-for-profit health care provider serving Wisconsin.
3000 W. Montana St., Milwaukee, WI 53215, (414) 647-3000
Disclaimer | Privacy notice | Contact us
.